Arcinova Q2 Newsletter 2017
Our Q2 Newsletter, with important updates including the expansion of our capabilties, new starters and upcoming conferences.
Arcinova Invests in Uniqsis FlowSyn™ Continuous Flow Reactor
In order to facilitate API development, Arcinova have invested in a Uniqsis FlowSyn™ continuous flow reactor.
Integrated Services: Covance and Arcinova strategic relationship
A strategic relationship has been formed between Arcinova and global CRDO Covance. The two companies are now providing integrated services to the global biotech and pharma industry.
Enterprise Hub founding Chair to receive President’s Medal
Director at Arcinova, Ian Shott, is set to receive the President's Medal for his many contributions to the work of the academy over the years, which has ultimately resulted in the creation of the Enterprise Hub.
FW Capital: Arcinova set to grow with £750,000 investment
Alnwick-based independent pharmaceutical contract research and development business Arcinova is set to grow thanks to a £750,000 investment via a loan from the North East Growth Plus Fund managed by FW Capital.
Arcinova Q1 Newsletter 2017
Our Q1 Newsletter, with important updates including the expansion of our capabilties, new starters and upcoming conferences.
Rural Funding Helps Arcinova Expand Capabilities
With the help of Arch Business, Arcinova have received funding from the Rural Growth Network Fund to support the installation of 20L API streams.
Arcinova Invests in State of the Art LC-MS Equipment
Arcinova have invested in the latest Waters Xevo® TQ-XS Triple Quadrupole Mass Spectrometry system.
French Tax Authority Grants Arcinova with R&D Organisation Status
An application to the French Tax Authority for 'R&D organisation' status has now been approved.